VANCOUVER, BC / ACCESSWIRE / January 5, 2017 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) will be joining Energous Corporation (NASDAQ: WATT) at the upcoming CES, one of the
VANCOUVER, BC / ACCESSWIRE / December 8, 2016 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces the addition of Mr. Michael Rhodes to its executive management team. Mr. Rhodes
VANCOUVER, BC / ACCESSWIRE / November 30, 2016 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) announces partnership with Dr. David J. Whellan and Thomas Jefferson University in Philadelphia for
VANCOUVER, BC / ACCESSWIRE / November 22, 2016 / CVR Medical Corp. CVR Medical Corp. (TSX.V:CVM) (FRANKFURT: B3BN) (OTCQB: CRRVF) (“CVR Medical“) is pleased to announce that that it has commenced trading on the OTCQB Marketplace
VANCOUVER, BC / ACCESSWIRE / November 15, 2016 / CVR Medical Corp. (CVM.V) (“CVR Medical“) is pleased to announce that CVR Global, its joint venture partner, has named Dr. Douglas Weaver to its Board of
VANCOUVER, BC / ACCESSWIRE / November 2, 2016 / CVR Medical Corp. (CVM.V) (“CVR Medical“) has entered into agreements with Tekna Incorporated, who will design and manufacture the cart for its “Carotid Stenotic Scan” (CSS)
October 20, 2016 – Vancouver, British Columbia (TSX-V: CVM) CVR Medical Corp. (“CVR Medical”) has appointed Dr. Paul S. Blunden to its Board of Directors. From this position, Dr. Blunden will serve in interpretive and
CVR Medical Corp (CVM.V) (Previously Big Bar Resources Corp) shares resumed trading on September 27, 2016 following TSX Venture Exchange Inc. acceptance of the previously submitted Change of Business and accompanying Joint Venture with CVR
October 12, 2016 – Vancouver, British Columbia (TSX-V: CVM) CVR Medical Corp. (“CVR Medical”) is pleased to announce that it has entered into an agreement with Venture Liquidity Providers Inc. (“VLP”), subject to regulatory approval,
Vancouver, British Columbia (TSX-V: CVM) CVR Medical Corp. (“CVR Medical”) is pleased to announce that it has entered into a consulting agreement effective as of September 27, 2016 with Brisco Capital Partners Corp. (“Brisco Capital”)
September 27, 2016 – Vancouver, British Columbia (TSX-V: CVM) CVR Medical Corp. (the “Company”) is pleased to announce it resumed trading on the TSX Venture Exchange (the “Exchange”) on September 27, 2016 following the close
September 16, 2016 – Vancouver, British Columbia (NEX Board of TSX-V: BBR.H) Big Bar Resources Corporation (“Big Bar” or the “Company”) is pleased to announce that a majority of shareholders have consented in writing in
CVR Medical Corp. is a med-tech organization dedicated to the development and advancement of revolutionary technology at work within the healthcare sector. Specifically, The Carotid Stenotic Scan (CSS), a groundbreaking tool which will be used to assess Carotid Arterial health in a way which is unavailable to the patient, healthcare provider, and the payor within the current system. By leveraging intellectual property, market and industry know-how, and key strategic relationships, CVR Medical has entered into a trajectory which will revolutionize healthcare and dramatically improve clinical outcomes.